Human medicines European public assessment report (EPAR): Tafinlar, dabrafenib, Melanoma, Date of authorisation: 26/08/2013, Revision: 29, Status: Authorised | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 1 September 2023 - 8:36

Human medicines European public assessment report (EPAR): Tafinlar, dabrafenib, Melanoma, Date of authorisation: 26/08/2013, Revision: 29, Status: Authorised

Link:

https://www.ema.europa.eu/en/medicines/human/EPAR/tafinlar

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters